ArticleOncology letters2018

Two protein-coding genes act as a novel clinical signature to predict prognosis in patients with ovarian serous cystadenocarcinoma.

Jue Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.